Encephalopathy in children with chronic renal failure

Area of Science:

• Pediatric Nephrology
• Neuroscience
• Toxicology

Background:

• Progressive encephalopathy in children with chronic renal failure mimics adult dialysis encephalopathy but is not dialysis-related.
• Renal osteodystrophy is more severe in children, often treated with aluminum-containing antacids.
• Secondary hyperparathyroidism is common in pediatric chronic renal failure.

Purpose of the Study:

• To investigate the cause of progressive encephalopathy in children with chronic renal failure.
• To explore the role of aluminum ingestion and secondary hyperparathyroidism in pediatric encephalopathy.
• To suggest alternative management strategies for chronic renal failure in children.

Main Methods:

• Clinical observation of 5 children with chronic renal failure and encephalopathy.
• Analysis of the association between aluminum antacid use, secondary hyperparathyroidism, and encephalopathy.
• Implementation of reduced aluminum compound dosage and parathyroidectomy in affected patients.

Main Results:

• Encephalopathy in children was clinically similar to adult dialysis encephalopathy but not linked to dialysis.
• Reduced aluminum compound dosage (50-100 mg/Kg/day) was implemented over 18 months.
• No new cases of encephalopathy occurred after dose reduction and parathyroidectomy recommendation.

Conclusions:

• Oral aluminum ingestion, particularly with persistent secondary hyperparathyroidism, may cause encephalopathy in children with chronic renal failure.
• Alternative methods for phosphorus control and reevaluation of parathyroidectomy indications are recommended.
• Lowering aluminum intake and surgical intervention appear effective in preventing further cases.